´ëÇѳ»ºÐºñÇÐȸ (¿Â¶óÀÎ) AOCE-SICEM 2020 Virtual Congress : 2020-10-30±³À°ÀÏÀÚ : 2020-10-30
±³À°Àå¼Ò : ¿Â¶óÀÎ ±³À°
±³À°ÁÖÁ¦ :
(¿Â¶óÀÎ) AOCE-SICEM 2020 Virtual Congress ÁÖÃÖ±â°ü : ´ëÇѳ»ºÐºñÇÐȸ
´ã´çÀÚ : ÇмúÀ§¿øȸ
¿¬¶ôó : 02-564-4367
À̸ÞÀÏ :
aoce-sicem2020@intercom.co.kr ±³À°Á¾·ù : ³»°ú, ¿Ü°ú, ÇÙÀÇÇаúÀÇ»çÇÐ, ºÐÀÚ»ý¹°ÇÐ,
Âü¼®¿¹»óÀοø : 1500¸í
Èñ¸ÁÆòÁ¡ : 6Á¡
Áö¿ª :
¼¿ïƯº°½Ã±³À°½Ã°£ : 31 ½Ã°£ 50ºÐ
¼¼ºÎ¼ö°·á : 150,000¿ø
ºñ°í 1. ÀÇ»ç, ±³¼ö - KES ȸ¿ø: 10¸¸¿ø / KES ¹Ìȸ¿ø: 15¸¸¿ø 2. Àü°øÀÇ, ÀüÀÓÀÇ, °£È£»ç, ¿¬±¸ÀÚ, ±âŸ - KES ȸ¿ø: 5¸¸¿ø / KES ¹Ìȸ¿ø: 10¸¸¿ø * º» Çà»ç´Â LIVE°ÀÇ¿Í ³ìÈµÈ VOD°ÀÇ·Î ÁøÇàµÇ¸ç, VOD °ÀǵéÀº ¾Æ·¡ ½Ã°£¿¡ °ü°è¾øÀÌ ´çÀÏ ÀÚÁ¤±îÁö ÆíÇѽ𣿡 º¼ ¼ö ÀÖµµ·Ï ¿î¿µÇÒ ¿¹Á¤ÀÔ´Ï´Ù.
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±âŸ 10¿ù 30ÀÏ ¿Â¶óÀÎ 08:30~08:50 Hot Issues ()
±³À°½Ã°£ 10¿ù 30ÀÏ ¿Â¶óÀÎ 08:50~09:30 Role of Autophagy in the Development and Treatment of Diabetes À̸í½Ä(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 10¿ù 30ÀÏ ¿Â¶óÀÎ 09:30~10:00 Heart Failure in Type 2 Diabetes- Pathophysiology and Impact of Glucose Lowering Therapies E. Dale Abel(The University of Iowa)
±³À°½Ã°£ 10¿ù 30ÀÏ ¿Â¶óÀÎ 10:00~10:30 SGLT2 Inhibition in Heart Failure Prevention and Treatment Richard Gilbert(University of Toronto)
±³À°½Ã°£ 10¿ù 30ÀÏ ¿Â¶óÀÎ 10:30~11:00 Heart Failure in Diabetes How Important and How to Assess? ¹ÚÁøÁÖ(ºÐ´ç¼¿ï´ëÇб³º´¿ø)
±³À°½Ã°£ 10¿ù 30ÀÏ ¿Â¶óÀÎ 11:00~11:30 The Impact of Race, Sex and Age on the Genetic Causes of Primary Aldosteronism University of Michigan(Àª¸®¾Ï ·¹ÀÌ´Ï)
±³À°½Ã°£ 10¿ù 30ÀÏ ¿Â¶óÀÎ 11:30~12:00 Genotypes Based Novel Classification of Aldosterone Producing Adenoma (APA) Tohoku University(È÷·Î³ëºÎ »ç»ç³ë)
±³À°½Ã°£ 10¿ù 30ÀÏ ¿Â¶óÀÎ 12:00~12:30 Steroid Signatures of Primary Aldosteronism ÃÖ¸¸È£(Çѱ¹°úÇбâ¼ú¿¬±¸¿ø)
ÈÞ½Ä 10¿ù 30ÀÏ ¿Â¶óÀÎ 12:30~13:30 ÈÞ½Ä ()
±âŸ 10¿ù 30ÀÏ ¿Â¶óÀÎ 13:30~13:50 Endocrine Quiz ¼ÕÀå¿ø(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 10¿ù 30ÀÏ ¿Â¶óÀÎ 13:50~14:30 To be Discussed Ronald Evans(Salk Institute)
±³À°½Ã°£ 10¿ù 30ÀÏ ¿Â¶óÀÎ 14:30~15:00 Integrated Perception of Hereditary Pheochromocytoma/paraganglioma(PPGL) Roderick Clifton-Bligh(University of Sydney)
±³À°½Ã°£ 10¿ù 30ÀÏ ¿Â¶óÀÎ 15:00~15:30 Parathyroid Carcinoma in Korea: Proteomics Approach °ø¼ºÇý(¼¿ï´ëÇб³º´¿ø)
±³À°½Ã°£ 10¿ù 30ÀÏ ¿Â¶óÀÎ 15:30~16:00 Janus-faced Pancreatic Neuroendocrine Tumor (PNET) ¹æ½Â¹Î(¿¬¼¼´ëÇб³ ÀÇ°ú´ëÇÐ ³»°úÇб³½Ç ¼Òȱ⳻°ú)
±³À°½Ã°£ 10¿ù 30ÀÏ ¿Â¶óÀÎ 16:00~16:40 ³²°îÇмú»ó ¹ßÇ¥ ¹ÌÁ¤(¹ÌÁ¤)
±âŸ 10¿ù 30ÀÏ ¿Â¶óÀÎ 16:40~17:30 AOCE Award & Closing ()
±âŸ 10¿ù 30ÀÏ ¿Â¶óÀÎ 17:30~17:50 Daily Highlights ()
±³À°½Ã°£ 10¿ù 30ÀÏ ¿Â¶óÀÎ 09:00~09:30 Genetics in Primary Aldosteronism Maria-Christina Zennaro(Inserm Université de Paris)
±³À°½Ã°£ 10¿ù 30ÀÏ ¿Â¶óÀÎ 09:30~10:00 Genetics of Pheochromocytoma/Paraganglioma ±èÁ¤Èñ(¼¿ïÀÇ´ë)
±³À°½Ã°£ 10¿ù 30ÀÏ ¿Â¶óÀÎ 10:00~10:30 Adrenocortical Carcinoma: What¡¯s New Today Where is Hope Tomorrow Gary Hammer(University of Michigan)
±³À°½Ã°£ 10¿ù 30ÀÏ ¿Â¶óÀÎ 09:00~09:30 Serotonergic Regulation of Hepatic Energy Metabolism ±èÇÏÀÏ(Çѱ¹°úÇбâ¼ú¿ø)
±³À°½Ã°£ 10¿ù 30ÀÏ ¿Â¶óÀÎ 09:30~10:00 WISP1 Activates MRTF to Promote the Progression of Established Liver Fibrosis Ning Ding(Genentech Inc.)
±³À°½Ã°£ 10¿ù 30ÀÏ ¿Â¶óÀÎ 10:00~10:30 Role of CRTC2 in Nonalcoholic Fatty Liver Disease ±¸½Âȸ(°í·Á´ëÇб³ »ý¸í°úÇкÎ)
±³À°½Ã°£ 10¿ù 30ÀÏ ¿Â¶óÀÎ 09:00~09:30 Lysosomal Signaling in Metabolism and Autophagy À̸í½Ä(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 10¿ù 30ÀÏ ¿Â¶óÀÎ 09:30~10:00 To be Discussed Ronald Evans(Salk Institute)
±³À°½Ã°£ 10¿ù 30ÀÏ ¿Â¶óÀÎ 10:00~10:30 Functions of Lipid GPCRs (FFA4 and S1P2) in Allergic and Inflammatory Diseases ÀÓµ¿¼ø(°æÈñ´ëÇб³)
±³À°½Ã°£ 10¿ù 30ÀÏ ¿Â¶óÀÎ 11:00~11:30 Diabetic Bone Disease Yu Cho Woo(The University of Hong Kong)
±³À°½Ã°£ 10¿ù 30ÀÏ ¿Â¶óÀÎ 11:30~12:00 Thyroid and Bone Disease È«¾Æ¶÷(ȼøÀü³²´ëÇб³º´¿ø)
±³À°½Ã°£ 10¿ù 30ÀÏ ¿Â¶óÀÎ 12:00~12:30 GIOP Jacques Brown(CHU Quebec)
±³À°½Ã°£ 10¿ù 30ÀÏ ¿Â¶óÀÎ 11:00~11:30 Muscle Aging and Neuromuscular Function °Á¾¼ø(¼º±Õ°ü´ëÇб³)
±³À°½Ã°£ 10¿ù 30ÀÏ ¿Â¶óÀÎ 11:30~12:00 Resistance Training and Muscle Stem Cell So-ichiro Fukada(Osaka University)
±³À°½Ã°£ 10¿ù 30ÀÏ ¿Â¶óÀÎ 11:00~11:30 Overview Real-time CGM in 2020 Áø»ó¸¸(¼º±Õ°üÀÇ´ë »ï¼º¼¿ïº´¿ø)
±³À°½Ã°£ 10¿ù 30ÀÏ ¿Â¶óÀÎ 11:30~12:00 Real-world Data of Hybrid Closed-loop Robert Vigersky(Medtronic)
±³À°½Ã°£ 10¿ù 30ÀÏ ¿Â¶óÀÎ 12:00~12:30 Free Style Libre Mahmood Kazemi(Abbott)
±³À°½Ã°£ 10¿ù 30ÀÏ ¿Â¶óÀÎ 11:00~11:30 Real-time CGM, Sensor-Augmented Pump in T1D ±èÀçÇö(ºÐ´ç¼¿ï´ëº´¿ø ¼Ò¾Æ°ú)
±³À°½Ã°£ 10¿ù 30ÀÏ ¿Â¶óÀÎ 11:30~12:00 Recent Advance in Body Composition Assessment To Be Discussed(InBody)
±³À°½Ã°£ 10¿ù 30ÀÏ ¿Â¶óÀÎ 12:00~12:30 Brain-derived Neurotrophic Factor: It Wayne Huey-Herng Sheu(Taichung Veterans General Hospital Taichung Taiwan)
±³À°½Ã°£ 10¿ù 30ÀÏ ¿Â¶óÀÎ 13:00~13:30 Liraglutide 3.0 mg À̽Âȯ(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 10¿ù 30ÀÏ ¿Â¶óÀÎ 13:30~14:00 Qsymia Scott Kahan(Johns Hopkins University)
±³À°½Ã°£ 10¿ù 30ÀÏ ¿Â¶óÀÎ 14:00~14:30 Injectable Semaglutide for Obesity Treatment Salvatore Calanna(Novo Nordisk)
±³À°½Ã°£ 10¿ù 30ÀÏ ¿Â¶óÀÎ 13:00~13:30 Ectopic Fat Cardiometabolic Perspective ÀÓ¼ö(¼¿ïÀÇ´ë)
±³À°½Ã°£ 10¿ù 30ÀÏ ¿Â¶óÀÎ 13:30~14:00 Sustain-China Linong Ji(Peking University People¡¯s Hospital)
±³À°½Ã°£ 10¿ù 30ÀÏ ¿Â¶óÀÎ 13:00~13:30 Gut Microbiome and Sex Steroid ½Åµ¿¹Ì(¼¿ï´ëÇб³)
±³À°½Ã°£ 10¿ù 30ÀÏ ¿Â¶óÀÎ 13:30~14:00 Gut Microbiome and Women¡¯s Health Omry Koren(Bar-Ilan University Azrieli Faculty of Medicine)
±³À°½Ã°£ 10¿ù 30ÀÏ ¿Â¶óÀÎ 14:00~14:30 Gut Microbiome and Obesity ¹®Ã¢¸ð(ÀÌÈ¿©ÀÚ´ëÇб³ ÀÇ°ú´ëÇÐ)
±³À°½Ã°£ 10¿ù 30ÀÏ ¿Â¶óÀÎ 15:00~15:30 Diagnostic Challenge in Cushing Syndrome Çã±Ô¿¬(»ï¼º¼¿ïº´¿ø)
±³À°½Ã°£ 10¿ù 30ÀÏ ¿Â¶óÀÎ 15:30~16:00 Dopamine Agonists: The Good and the Bad Carmela Caputo(St Vincent¡¯s Hospital Melbourne Australia)
±³À°½Ã°£ 10¿ù 30ÀÏ ¿Â¶óÀÎ 15:00~15:30 Updates in Diagnosis of Anterior Pituitary Hormone Deficiency Áø»ó¿í(°æÈñ´ëÇб³ ÀÇ°ú´ëÇÐ)
±³À°½Ã°£ 10¿ù 30ÀÏ ¿Â¶óÀÎ 15:30~16:00 Management of Immune-related Adverse Events in Endocrine Organs Induced by Immune Checkpoint Inhibitors Hiroshi Arima(Nagoya University Graduate School of Medicine)
±³À°½Ã°£ 10¿ù 30ÀÏ ¿Â¶óÀÎ 16:00~16:30 Aggressive Pituitary Tumors Ann McCormack(St Vincent¡¯s Hospital)
±³À°½Ã°£ 10¿ù 30ÀÏ ¿Â¶óÀÎ 15:00~15:30 Traditional Genetic Analysis on Monogenic Disorders and What Has Been Changed ±è±¸È¯(¼¿ï¾Æ»êº´¿ø)
±³À°½Ã°£ 10¿ù 30ÀÏ ¿Â¶óÀÎ 15:30~16:00 Complex Inheritance of Common Multifactorial Disorders ÃÖ¹«¸²(¼¿ï´ëÇб³)
±³À°½Ã°£ 10¿ù 30ÀÏ ¿Â¶óÀÎ 16:00~16:30 Computational Analysis of Somatic Mutations: From Cancer to Neurogenetic Diseases ±è»ó¿ì(¿¬¼¼´ëÇб³ ÀÇ°ú´ëÇÐ)
±³À°½Ã°£ 10¿ù 30ÀÏ ¿Â¶óÀÎ 16:30~17:00 Characteristics of Stem Cell/Progenitor Cells in Thyroid Shioko Kimura(USA National Cancer Institute)
±³À°½Ã°£ 10¿ù 30ÀÏ ¿Â¶óÀÎ 17:00~17:30 NAFLD & Thyroid Hormone Paul M Yen(Duke-NUS Medical School)
±³À°½Ã°£ 10¿ù 30ÀÏ ¿Â¶óÀÎ 17:30~18:00 Cerebellum Development & Thyroid Hormone Noriyuki Koibuchi(Gunma University Graduate School of Medicine)
±³À°½Ã°£ 10¿ù 30ÀÏ ¿Â¶óÀÎ 16:30~17:00 Recent Updates of Molecular Targeted Treatment for Advanced Thyroid Cancer Naomi Kiyota(Kobe University Hospital)
±³À°½Ã°£ 10¿ù 30ÀÏ ¿Â¶óÀÎ 17:00~17:30 New Targeted Therapies for Advanced Thyroid Cancer ±è¹ü¼®(¼¿ï´ëº´¿ø)
±³À°½Ã°£ 10¿ù 30ÀÏ ¿Â¶óÀÎ 17:30~18:00 Non-surgical Treatment for Recurrent Thyroid Cancer ¹éÁ¤È¯(¼¿ï¾Æ»êº´¿ø)
±³À°½Ã°£ 10¿ù 30ÀÏ ¿Â¶óÀÎ 16:30~17:00 Novel Hormones Skeletal Muscle and Brown Adipose Tissue E. Dale Abel(The University of Iowa)
±³À°½Ã°£ 10¿ù 30ÀÏ ¿Â¶óÀÎ 17:00~17:30 Interorgan Crosstalk through Adipose Tissue Exosomes Clair Crewe(UT Southwestern Medical Center)
±³À°½Ã°£ 10¿ù 30ÀÏ ¿Â¶óÀÎ 17:30~18:00 Steroid Profiling in Diagnosing Indeterminate Adrenal Mass Irina Bancos(Mayo Clinic)
±³À°½Ã°£ 10¿ù 30ÀÏ ¿Â¶óÀÎ 16:30~17:00 ¿¬±¸¼Ò: AI ±â¹ÝÀÇ ºñ´ë¸éÀǷἺñ½º ÀÌ°À±(°¡ÃµÀÇ´ë)
±³À°½Ã°£ 10¿ù 30ÀÏ ¿Â¶óÀÎ 17:00~17:30 ±â¾÷: Çѱ¹ Àç¿Üµ¿Æ÷ ºñ´ë¸é Áø·á Ç÷§Æû ¹è¹Îö(¶óÀÌÇÁ½Ã¸Çƽ½º)
±³À°½Ã°£ 10¿ù 30ÀÏ ¿Â¶óÀÎ 17:30~18:00 º´¿ø: ´ç´¢º´ ºñ´ë¸é Áø·á½Ã °í·Á»çÇ× Á¶ÀçÇü(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 10¿ù 30ÀÏ ¿Â¶óÀÎ 16:30~16:55 Application of Bundled Payment System in Endocrinology ¹Ú°æÇý(±¹¹Î°Ç°º¸Çè Àϻ꺴¿ø)
±³À°½Ã°£ 10¿ù 30ÀÏ ¿Â¶óÀÎ 16:55~17:20 The Problems and Improvement Strategies of New Bundled Payment Â÷Àç¸í(°æÈñÀÇ´ë)
Åä·Ð 10¿ù 30ÀÏ ¿Â¶óÀÎ 17:20~17:50 Discussion ()